tirzepatide for psoriatic arthritis Taltz plus promising in arthritis, obesity Taltz and Zepbound combo improves

A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (Award-8)

Several sensitivity analyses with different structural PK parameters and different procedures for LLOQ handling were conducted, all demonstrating robust C avg values, with above 0.99 correlation to the final estimates

Give the Gift of Wellness

Prescription treatment requires evaluation by a licensed clinician

Declarations Ethics approval and consent to participate This article is based on open-label data and does not contain any new studies conducted by authors on human participants or animals and does not require ethical approval